JPM Thematics - Genetic Therapies C2 (dist) - CHF (hedged)/  LU2053353749  /

Fonds
NAV20/05/2024 Chg.+0.6200 Type de rendement Focus sur l'investissement Société de fonds
92.9400CHF +0.67% paying dividend Equity JPMorgan AM (EU)